Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Inactivated vs Live Attenuated HAV Vaccine in Young Adults
NCT01865968Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Oct 2008
- Primary completion
- Dec 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis A vaccine (inactivated) in hepatitis A (HAV), sponsored by Sinovac Biotech Ltd.. Started Oct 2008; status: completed.
02
Drugs
hepatitis A vaccine (inactivated)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT01865968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01865968.